Li Kang Biomedical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 10, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,218	1,364	1,563	1,315	872	824
Market Cap Growth	-12.75%	-12.69%	18.87%	50.69%	5.93%	-7.83%
Enterprise Value	1,157	996	1,413	1,116	788	687
Last Close Price	38.30	40.91	52.92	41.96	27.00	23.89
PE Ratio	14.94	17.72	14.08	11.73	16.96	11.89
PS Ratio	2.09	2.41	2.48	1.92	2.26	1.80
PB Ratio	1.44	1.60	2.48	2.31	1.77	1.62
P/TBV Ratio	1.45	1.60	2.49	2.31	1.77	1.62
P/FCF Ratio	-	518.62	16.72	8.42	15.53	10.31
P/OCF Ratio	17.31	20.87	16.15	8.36	14.43	10.09
EV/Sales Ratio	1.99	1.76	2.25	1.63	2.04	1.50
EV/EBITDA Ratio	11.00	9.92	9.88	7.52	11.23	7.16
EV/EBIT Ratio	12.13	11.06	10.59	8.12	13.76	8.49
EV/FCF Ratio	-4.68	378.39	15.12	7.15	14.02	8.60
Debt / Equity Ratio	0.21	0.11	0.14	-	0.07	0.08
Debt / EBITDA Ratio	1.67	0.90	0.63	-	0.48	0.43
Debt / FCF Ratio	-	34.94	0.97	-	0.60	0.51
Net Debt / Equity Ratio	-0.07	-0.42	-0.33	-0.46	-0.29	-0.35
Net Debt / EBITDA Ratio	-0.58	-3.61	-1.47	-1.78	-2.03	-1.87
Net Debt / FCF Ratio	0.25	-137.77	-2.25	-1.69	-2.53	-2.25
Asset Turnover	0.54	0.61	0.83	1.05	0.61	0.72
Inventory Turnover	3.56	4.14	5.40	9.13	3.75	4.93
Quick Ratio	0.95	4.93	2.83	2.31	2.08	2.46
Current Ratio	1.22	5.45	3.24	2.61	2.45	2.83
Return on Equity (ROE)	9.80%	10.37%	18.50%	21.11%	10.28%	13.97%
Return on Assets (ROA)	5.54%	6.04%	11.00%	13.16%	5.67%	7.96%
Return on Invested Capital (ROIC)	11.55%	15.31%	26.03%	33.32%	13.67%	19.32%
Return on Capital Employed (ROCE)	10.60%	9.60%	18.60%	24.10%	10.80%	14.70%
Earnings Yield	6.73%	5.64%	7.10%	8.53%	5.90%	8.41%
FCF Yield	-20.28%	0.19%	5.98%	11.87%	6.44%	9.70%
Dividend Yield	5.22%	4.89%	4.72%	4.15%	4.60%	9.71%
Payout Ratio	77.54%	103.24%	42.00%	29.71%	120.85%	64.10%
Buyback Yield / Dilution	-6.78%	-15.70%	-	-0.10%	0.23%	-0.05%
Total Shareholder Return	-1.56%	-10.81%	4.72%	4.04%	4.83%	9.66%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.